Cut Zetia in half, Cut Zetia Sales estimates in half.

Article Submitted by: pharmaking
Stocks - Options - Mutual Funds


Tags: Mrk, Sgp, Vytorin, Zetia.

More bad news for MRK and SGP. A presentation which hadn't gathered any pre-meeting publicity shows that cutting zetia in half can half costs, while not altering affect on lipids.

Chapters:

1

Submitted: Nov 4, 2007    Views: 902    Comments: 0    Likes: 18   


Another abstract from the AHA (3728, by Baruch et al. ) which will be released at the meeting this week shows that 5mg of Zetia is just as effective as 10mg of zetia either alone or when combined with a statin. The presentation suggests that cutting zetia in half( or presumably prescribing higher dose vytorin and then cutting it in half) could save our healthcare system a lot of money. They reported that by making 5mg the mandatory starting dose at their institution, they saved $40,000 at their hospital alone.

In this era of healthcare cost control, this is an easy change with no downside. I would expect this data to over time reduce sales of zetia and vytorin. Don’t expect MRK or SGP to talk about these results, but the data will filter out.


Sponsor Updates and Offers

Sign up for Zions Direct’s free weekly newsletter.

Get market information, CD and Bond auction updates, new-issue alerts and more.



Related Articles:



18

Email this story Email to someone | Print Story Print Content | Add to reading list



Add Your Comments:

Your Name:

Spam protection control:


© Copyright 2010 pharmaking All rights reserved. pharmaking has granted BestCashCow.com, LLC non-exclusive rights to display this work on Bestcashcow.com.

Financial products of all nature bear inherent risks and this website is not a financial advisory service; it is a forum for users to share and to compare notes and observations on financial publications. The website provides, free of charge, the technical and logistical apparatus and the medium for users to share and to publish financial information and to comment on publications. As such, the website's operator can not and does not take responsibility for information, observations or opinions of any sort or nature provided by third parties with whom it is not affiliated who use the website to publish, to comment or as a means of solicitation. Users are specifically warned against following any advice related to specific instruments, including, but not limited to, equity securities, that may be provided by other users directly on this site or on web pages to which other users have provided links on this site. BestCashCow.com can not and does not check or verify the qualifications and credentials of users who publish or comment on this site or on linked pages. Users should seek personalized advice from qualified professionals regarding all personal financial issues and evaluate the risks and applicability to their own circumstances of each financial product discussed regardless of who the publisher is or purports to be. Should you, through your use of this site, identify an individual or organization purporting to offer personalized advice, you bear all responsibility to ensure that the individual or organization has the qualifications that they may represent on the website, and that their advice is appropriate for your circumstances. On certain webpages, BestCashCow.com provides information related to rates on US-based savings accounts, CDs, short-term government bonds, and other US cash equivalent securities, also free of charge to internet users for their independent use. The accuracy of this information is not guaranteed, and the information, like all other information on this website, should not be construed to provide investment advice, nor to endorse a financial product of any sort.

© 2010 BestCashCow.com, LLC. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy.